Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity
- PMID: 2021957
- PMCID: PMC11037951
- DOI: 10.1007/BF01742527
Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity
Abstract
Human peripheral blood mononuclear cells (lymphocytes and monocytes) (PBMC) were preincubated for 0-24 h with human recombinant interleukin-4 (IL-4) and used as effector cells in an 18 h antibody-dependent cellular cytotoxicity (ADCC) assay with mAb 17-1A (mouse IgG2A) against SW948 (a human colorectal carcinoma cell line). A statistically significant increase in the lytic capability was noted after 2-24 h of preactivation. IL-4 at 1 ng/ml induced the highest cell lysis while higher and lower concentrations were inferior or had no effect at all. Preactivation for 24 h induced a more effective lytic cell population than 2 h prestimulation: 63 LU (lytic units)/10(6) cells vs 42 LU/10(6) cells. Pretreatment with 1 ng/ml IL-4 for 2 h induced a statistically significant increase in the ADCC activity of PBMC (P less than 0.05), of monocytes (P less than 0.01) and E-rosette-negative cells (natural killer cells) (P less than 0.05) compared to non-activated cells. IL-4 did not induce lymphokine-activated killer activity of PBMC against SW948. The spontaneous cytotoxicity against K562 was, however, increased after stimulation with 1 ng/ml IL-4 for 2 h of E-rosette-negative non-adherent cells.
Similar articles
-
Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.Cancer Immunol Immunother. 1989;29(4):288-92. doi: 10.1007/BF00199217. Cancer Immunol Immunother. 1989. PMID: 2665935 Free PMC article.
-
Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).Hybridoma. 1988 Oct;7(5):429-40. doi: 10.1089/hyb.1988.7.429. Hybridoma. 1988. PMID: 3198133
-
Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.Z Gastroenterol. 2000 Aug;38(8):615-22. doi: 10.1055/s-2000-7511. Z Gastroenterol. 2000. PMID: 11031784
-
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.Jpn J Cancer Res. 1994 Feb;85(2):194-203. doi: 10.1111/j.1349-7006.1994.tb02082.x. Jpn J Cancer Res. 1994. PMID: 7511575 Free PMC article.
-
Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.Jpn J Cancer Res. 1996 May;87(5):497-504. doi: 10.1111/j.1349-7006.1996.tb00251.x. Jpn J Cancer Res. 1996. PMID: 8641987 Free PMC article.
Cited by
-
Chemotherapy and immunotherapy of colorectal cancer.Med Oncol Tumor Pharmacother. 1991;8(3):207-20. doi: 10.1007/BF02987181. Med Oncol Tumor Pharmacother. 1991. PMID: 1803182 Review.
-
Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC).Mediators Inflamm. 1994;3(6):419-24. doi: 10.1155/S0962935194000591. Mediators Inflamm. 1994. PMID: 18475590 Free PMC article.
-
Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.Invest New Drugs. 1992 Nov;10(4):269-73. doi: 10.1007/BF00944180. Invest New Drugs. 1992. PMID: 1487400
-
Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.Int J Mol Sci. 2021 Jan 13;22(2):727. doi: 10.3390/ijms22020727. Int J Mol Sci. 2021. PMID: 33450900 Free PMC article. Review.
References
-
- Bøyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol. 1983;17:429. - PubMed
-
- Coffman RL, Ohara J, Bond MW, Cartz J, Zlotnik A, Paul WE. B-cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol. 1986;136:4538. - PubMed
-
- Crawford RM, Finbloom DS, Ohara J, Paul WE, Meltzer MS. B-cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol. 1987;139:135. - PubMed
-
- Fanger MW, Shen L, Graziano RF, Guyre PM. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today. 1989;10:92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous